MedTrace Logo

Randomized Clinical Trial of Triptolide Woldifii for Autosomal Dominant Polycystic Kidney Disease

NCT00801268 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2015-03-30

No results posted yet for this study

Summary

Triptolide has been approve effective in animal model.

Conditions

  • Polycystic Kidney

Interventions

DRUG

tripterygium wilfordii

TW，60mg/d

DRUG

Emodin

100mg/d

Sponsors & Collaborators

  • Zhi-Hong Liu, M.D.

    lead OTHER

Principal Investigators

  • Liu Zhihong, Master · Research Institute of Nephrology, Jinling Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
15 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2013-11-30
Completion
2013-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801268 on ClinicalTrials.gov